CDC reports a new strain of omicron taking over in the U.S.
About 40% of confirmed U.S. Covid cases are caused by the XBB.1.5 strain, up from 20% a week ago.
Research in action: Halo’s pan-coronavirus antivirals explained.
What was it like to keep research work going during the worst of the pandemic? And how close are we to a vaccine that works against all current and future coronavirus variants?
Conserved binding pocket is net positive for deadly coronavirus strains
Investigators at the University of Bristol and Biognos AB have identified a structural feature that distinguished the deadly coronavirus strains from harmless, common cold-causing variants. The findings, which were published in the Nov. 23, 2022
Scientists find tailor-made pocket feature shared by coronaviruses causing severe disease
Scientists have discovered that a tailor-made pocket within the SARS-CoV-2 spike protein, which is capable of binding itself to the human cell surface, is what results in some coronaviruses causing severe disease.
Halo scientists reveal Achilles’ heel of deadly coronaviruses from SARS-CoV to Omicron
The free fatty acid–binding pocket is a conserved hallmark in pathogenic β-coronavirus spike proteins from SARS-CoV to Omicron
Halo Therapeutics Winner at OBN Awards 2022 !
New survey suggests reinfection worsens Long COVID
Survey indicates that getting reinfected worsens symptoms of Long COVID or triggers a recurrence of symptoms in people who have recovered.
COVID ‘variant soup’ is making winter surges hard to predict
Descendants of Omicron are proliferating worldwide — and the same mutations are coming up again and again.
Some call it a swarm of variants — others refer to it as variant soup. Whatever it’s called, the current crop of immunity-dodging offshoots of the Omicron variant of SARS-CoV-2 is unprecedented in its diversity. This complexity makes it harder to predict coming waves of infection. It might even lead to a ‘double wave’ in some places, as first one variant and then another overtakes a population.
Halo Therapeutics selected finalist in OBN Awards 2022
The OBN Awards, now in their 14th year, are a highly regarded and sought-after awards programme for the Life Sciences industry, designed to celebrate innovation and outstanding achievement across all corners of the life sciences industry.
Global health solutions: Anti-virals innovation post-COVID
As long as humans inhabit the earth, viruses will be part of life, and learning how to defend against novel coronaviruses will be vital for global health.